Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 7/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.37 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5702291 | 0.84 | MAPK14 (0.43) | MAPK14KMT2AALDH1A1HPGDLMNA | |
| SCHEMBL5702334 | 0.70 | ALDH1A1 (0.44) | KMT2AALDH1A1HPGDLMNAHRH1 | |
| SCHEMBL252005 | 0.69 | HSD11B1 (0.42) | KMT2AALDH1A1HPGDLMNAHRH1 | |
| SCHEMBL7162982 | 0.68 | KDM4E (0.40) | KMT2AALDH1A1LMNAMEN1SMN1; SMN2 | |
| SCHEMBL15767958 | 0.68 | KDM4E (0.40) | KMT2AALDH1A1LMNAMEN1SMN1; SMN2 | |
| Benzoic Acid SCHEMBL11460148 | 0.68 | HRH1 (0.46) | KMT2AALDH1A1HPGDHRH1MEN1 | |
| Benzoic Acid SCHEMBL11463312 | 0.67 | OPRD1 (0.40) | KMT2AALDH1A1LMNAHRH1MEN1 | |
| Benzophenone SCHEMBL28043630 | 0.66 | CYP3A4 (0.57) | KMT2AALDH1A1HPGDLMNAHRH1 | |
| SCHEMBL2087994 | 0.66 | KDM4E (0.45) | KMT2AALDH1A1LMNAMEN1NPC1 | |
| SCHEMBL11329042 | 0.66 | HRH1 (0.39) | KMT2AALDH1A1HPGDLMNAHRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6420317-B1 | SELECTIVE CONTROL OF BROAD-LEAVED WEEDS AND WEED GRASSES IN CROPS OF USEFUL PLANTS, SUCH AS TRANSGENIC PLANTS | AVENTIS CROPSCIENCE GMBH (DE) | 2002-07-16 | — | — | US | disclosed |
| US-20020065200-A1 | Benzoylpyrazoles and their use as herbicides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2002-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020065200-A1 | Benzoylpyrazoles and their use as herbicides | CYP2E1, CBR3, CYP1B1 | MAPK14 2003/4885KMT2A 2495/4885ALDH1A1 153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.